Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Arena, Roberto ^a   Mathews, Christine E ^a   Kim, Anne Y ^b   Lenz, Tim E ^b   Southern, Paul M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPANOSOMA CRUZI;

EID: 79955410364     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-132     Document Type: Article

References (23)

1. Control of Chagas disease. World Health Organization Expert Committee, World Health Organ Tech Rep Ser 2002 905 i-vi l-109
2. Blood Donor Screening for Chagas Disease - United States, 2006-2007. Centers for Disease Control and Prevention, The Morbidity and Mortality Weekly Report (MMWR) 2007 56 7
3. Chagas disease after organ transplantation - United States, 2001. Centers for Disease Control and Prevention, The Morbidity and Mortality Weekly Report (MMWR) 2002 51 10
4. Chagas Disease After Organ Transplantation - Los Angeles, California, 2006. Centers for Disease Control and Prevention, The Morbidity and Mortality Weekly Report (MMWR) 2006 55 29
5. Oral transmission of Chagas disease by consumption of açaí palm fruit. AA Nábrega MH Garcia E Tatto MT Obara E Costa J Sobel WN Araujo, Brazil Emerg Infect Dis 2009 15 4 653 5 10.3201/eid1504.081450
6. Transmission of Trypanosoma cruzi by heart transplantation. H Kuh A Moore L Mascola F Steurer G Lawrence B Kubak S Radhakrishna D Leiby R Herron T Mone R Hunter M Kuehnert Chagas Disease in Transplant Recipients Investigation Team, Clin Infect Dis 2009 48 1534 40 10.1086/598931 19400748
7. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. DA Leiby RM Herron Jr G Garraty BL Herwaldt, J Infect Dis 2008 198 609 13 10.1086/590159 18588482
8. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. DA Leiby RM Herron Jr EJ Read BA Lenes RJ Stumpf, Transfusion 2002 42 549 55 10.1046/j.1537-2995.2002.00077.x 12084162
9. Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery. DA Leiby FJ Rentas KE Nelson VA Stambolis PM Ness C Parnis HA McAllister Jr DH Yawn RJ Stumpf LV Kirchhoff, Circulation 2000 102 24 2978 82 11113049
10. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. DA Leiby EJ Read BA Lenes AJ Yund RJ Stumpf LV Kirchhoff RY Dodd, J Infect Dis 1997 176 1047 52 10.1086/516534 9333165 (Pubitemid 27411049)
11. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors. LH Tobler P Contestable L Pitina H Groth S Shaffer GR Blackburn H Warren SR Lee MP Busch, Transfusion 2007 47 90 96 10.1111/j.1537-2995.2007.01068.x 17207235 (Pubitemid 46006314)
12. Chagas disease and the US blood supply. C Bern SP Montgomery L Katz S Caglioti SL Stramer, Curr Opin Infect Dis 2008 21 5 476 82 10.1097/QCO. 0b013e32830ef5b6 18725796
13. Chagas disease cardiomyopathy: current concepts of an old disease. AM Bilate E Cunha-Neto, Rev Inst Med Trop Sao Paulo 2008 50 2 67 74 10.1590/S0036-46652008007500001 18488083 (Pubitemid 351744065)
14. Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review. C Bern SP Montgomery BL Herwaldt, JAMA 2007 298 18 2171 81 10.1001/jama.298.18.2171 18000201 (Pubitemid 350106656)
15. Estimacion cuantitativa de la enfermedad de Chagas en las Americas. Organizacion Panamericana de la Salud, Organizacion Panamericana de la Salud Montevideo, Uruguay 2006
16. Changing epidemiology and approaches to therapy for Chagas disease. LV Kirchhoff, Curr Infect Dis Rep 2003 5 1 59 65 10.1007/s11908-003-0066-y 12525292 (Pubitemid 38899160)
17. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico. L Galavíz-Silva DP Molina-Garza MA Gonzlez-Santos R Mercado Hernndez JR Gonzlez-Galavíz JL Rosales-Encina ZJ Molina-Garza, Am J Trop Med Hyg 2009 81 3 404 6 19706904
18. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Y Jackson C Myers A Diana HP Marti H Wolff F Chappuis L Loutan A Gervaix, Emerg Infect Dis 2009 15 4 601 3 10.3201/eid1504.080438 19331743
19. Chagas Disease: A Latin American health problem becoming a world health problem. GA Schmunis ZE Yadon, Acta Trop 2009
20. An estimate of the burden of Chagas disease in the United States. C Bern SP Montgomery, Clin Infect Dis 2009 49 5 52 4 10.1086/605091 19640226
21. Clinical immunoparasitology. M Wilson PM Schantz T Nutman VCW Tsang, Manual of Clinical Laboratory Immunology Washington, D.C.: American Society for Microbiology, Rose NR, Hamilton RG, Detrick B, 6 2002 547 58
22. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. ES Umezawa MS Nascimento N Kesper Jr JR Coura J Borges-Pereira ACV Junqueira ME Camargo, J Clin Microbiol 1996 34 9 2143 47 8862574 (Pubitemid 26272193)
23. Riesgo de transmission de Trypanosoma cruzi por transfusion de sangre en Mexico. C Guzman-Bracho L Garcia-Garcia J Foriai S Guerrero-Martinez M Torres Cosme C Ramirez-Melgar O Velasco-Castrejon, Rev Panam Salud Publ 1998 4 94 99 10.1590/S1020-49891998000800004